Evidence map›Paper›PMID 42512274›Full record

ArticleCancers2026

Salvage Proton Therapy Re-Irradiation in Recurrent Head and Neck Cancer: Outcomes and Adverse Events by Re-Irradiated Target Site.

Enrique Amaya, Jacobo Palma, Roser Fayós-Solà, Rosa Meiriño, Mauricio Cambeiro, Ana Navarrete, Pablo Cabello-García, Alberto Viñals, Diego Pedrero, Felipe A Calvo and 2 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Enrique AmayaDepartment of Radiation Oncology, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0002-9055-6859
Jacobo PalmaDepartment of Radiation Oncology, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0002-8746-6844
Roser Fayós-SolàDepartment of Medical Physics, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0002-8250-854X
Rosa MeiriñoDepartment of Radiation Oncology, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0003-1676-7145
Mauricio CambeiroDepartment of Radiation Oncology, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0001-5959-7380
Ana NavarreteDepartment of Radiation Oncology, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0009-0008-1542-7724
Pablo Cabello-GarcíaDepartment of Medical Physics, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0003-2768-6316
Alberto ViñalsDepartment of Medical Physics, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0001-9158-7932
Diego PedreroDepartment of Medical Physics, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0002-0536-5127
Felipe A CalvoDepartment of Radiation Oncology, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0001-7574-546X
Javier AristuDepartment of Radiation Oncology, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0002-0382-2363
Javier SerranoDepartment of Radiation Oncology, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0002-0322-7863

Funding

Navarra University Clinic
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse eventhead and neck cancerIMPTlocoregional controloverall survivalproton therapyrecurrentre-irradiation

Identifiers

PMID42512274
PMCPMC13406275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.